Light adjustable lenses offer stability of refraction

Article

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Arturo Chayet from the Codet Vision Institute, Mexico and colleagues from the US conducted a prospective study implanting LALs that would purposely result in myopic errors of up to -1.5 D in 14 eyes of 14 patients. The LALs were treated with a spatial intensity profile to induce a targeted myopic refractive change. The LALs were treated again once the desired correction was achieved in order to 'lock in' the lens power.

Thirteen of the 14 eyes attained 0.25 D of the target refraction one day following the 'lock-in' and 100% of eyes achieved target refraction adjustment within 0.5 D during the 9-month follow-up period. No changes were recorded in manifest spherical refraction between the first day post 'lock-in' and the end of follow-up.

The researchers noted that the mean rate of refractive change was 0.006 D per month, making this treatment approach approximately six times more stable than laser corneal refractive procedures.

Click here to read the full abstract.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.